11:13 AM EST - Bausch + Lomb Corporation : Today announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the efficacy and safety of LUMIFY Preservative Free redness reliever eye drops compared to LUMIFY redness reliever eye drops for reducing ocular redness. Bausch + Lomb Corporation
shares T.BLCO are trading up $0.72 at $20.55.
